Collaborative Research to Explore New Uses for Existing Radioligands (R21/R33)

The summary for the Collaborative Research to Explore New Uses for Existing Radioligands (R21/R33) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Collaborative Research to Explore New Uses for Existing Radioligands (R21/R33): -Purpose. The National Institute on Drug Abuse (NIDA), the National Institute on Aging, the National Institute of Neurological Disorders and Stroke (NINDS), and the National Institute of Mental Health (NIMH), through the issuance of this Request for Applications (RFA), seeks to encourage broader uses of established PET/SPECT radioligands by reducing barriers to their wider distribution, and expanding their utility to the study of diseases or organs for which the radioligand has not previously been studied. Applications for this RFA should demonstrate a high degree of innovation and novelty with regard to the new uses for existing radioligands. Although there is no requirement for preliminary data, a clear scientific rationale is essential. Applications for this RFA are expected to propose multi-institutional collaborations between investigators who have the capacity for routine production of a given radioligand for human use, and investigators who lack access to the radioligand but wish to demonstrate the feasibility of an innovative use for the radioligand in a novel patient population. The primary focus of the proposal must be on human studies; animal studies are allowable only if required to obtain regulatory approval for the ligands. -Mechanism of Support. This Funding Opportunity Announcement (FOA) will utilize the NIH Phased Innovation Award (R21/R33) grant mechanism. -Funds Available and Anticipated Number of Awards. This RFA has approximately $2.5M set aside to fund meritorious applications that address the goals of this solicitation. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. It is anticipated that between 8 - 10 proposals might be funded under this solicitation.
Federal Grant Title: Collaborative Research to Explore New Uses for Existing Radioligands (R21/R33)
Federal Agency Name: National Institutes of Health
Grant Categories: Health Education
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-DA-08-001
Type of Funding: Grant
CFDA Numbers: 93.24293.279
CFDA Descriptions: Mental Health Research Grants 93.279 Drug Abuse and Addiction Research Programs
Current Application Deadline: No deadline provided
Original Application Deadline: Jan 29, 2008
Posted Date: Aug 08, 2007
Creation Date: Aug 08, 2007
Archive Date: Feb 28, 2008
Total Program Funding: $2,000,000
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: 93.853 -- Extramural Research Programs in the Neurosciences and Neurological Disorders
Applicants Eligible for this Grant
County governments Others (see text field entitled "Additional Information on Eligibility" for clarification) Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education Public housing authorities/Indian housing authorities Native American tribal governments (Federally recognized) Public and State controlled institutions of higher education City or township governments Independent school districts Small businesses State governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Special district governments For profit organizations other than small businesses
Additional Information on Eligibility
Foreign institutions are eligible to apply. Eligible agencies of the Federal Government can apply. Faith-based or community-based organizations can apply.
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
More Grants from the National Institutes of Health
Ethical Issues in Translational Science Research (R01 Clinical Trial Optional)
A Collaborative Network to Optimize Emergency Care of Older Adults with Alzheimers Disease...
Innovations to Foster Healthy Longevity in Low-Income Settings (R03 Clinical Trial Not All...
HIV-associated Non-Communicable Diseases Research at Low- and Middle-Income Country Instit...
National Dental Practice-Based Research Network Clinical Trial or Observational Study Plan... is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2019